Today: 21 January 2026
Subscribe
Browse Category

NASDAQ:APP News 20 January 2026 - 21 January 2026

AppLovin stock slides again after CapitalWatch report alleges money-laundering ties — what investors watch next

AppLovin stock slides again after CapitalWatch report alleges money-laundering ties — what investors watch next

New York, Jan 21, 2026, 10:40 EST — Regular session Shares of AppLovin Corp fell 3.9% to $543.48 on Wednesday, deepening losses after a short seller report from CapitalWatch accused the company of money laundering connections and lax compliance controls. (Tradingview) The fresh hit is significant because AppLovin has emerged as a key indicator for the “AI-driven” pitch in mobile…
21 January 2026
···
AppLovin stock whipsaws after CapitalWatch report; Piper Sandler sticks with $800 target

AppLovin stock whipsaws after CapitalWatch report; Piper Sandler sticks with $800 target

New York, January 20, 2026, 16:56 ET — After-hours AppLovin Corp (APP.O) shares slipped roughly 0.6% to $565.52 in after-hours on Tuesday, following a damaging short-seller report that alleged the mobile ad software company has links to money laundering. The claims sparked a sharp selloff during the day. Investors, already pulling back from risk in U.S. stocks, showed little tolerance…
20 January 2026
·····
AppLovin stock whipsaws after CapitalWatch report as APP traders look to earnings next

AppLovin stock whipsaws after CapitalWatch report as APP traders look to earnings next

New York, January 20, 2026, 10:26 EST — Regular session underway. AppLovin Corp shares dropped Tuesday following a report from research firm CapitalWatch accusing the advertising software company of connections to illicit money flows. The stock slipped 1.2% to $562.21, after tumbling as much as 12% to $501.01 earlier in the day. The report arrives at a sensitive time for…
20 January 2026
·····

Stock Market Today

  • FBT ETF Sees Surging Volume Driven by Moderna and Gilead Shares
    January 21, 2026, 2:05 PM EST. The First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) experienced unusually high trading volume on Wednesday, surging to over 398,000 shares from a three-month average of around 28,000. FBT shares climbed about 2.5% amid significant activity in its components. Moderna led gains with a 10.5% rise, trading more than 10.6 million shares, while Gilead Sciences increased 2.8% on 2.2 million shares. In contrast, Exact Sciences showed minimal movement, up just 0.1%. This marked spike in biotech ETF volume highlights heightened investor interest particularly in leading pharmaceutical stocks.
Go toTop